PharmaBoardroom

While pledging to lower drug prices has proved popular, the Trump administration’s proposed FDA reform has been getting some pharmaceutical…

In an exclusive interview, Agnès Buzyn, Chairwoman of the Board for the French National Authority for Health (Haute Autorité de Santé – HAS), on…

Take our poll on Donald Trump and Pharma at the bottom of the article Speaking at a White House meeting with senior pharmaceutical executives, US…

In an exclusive interview, Luxembourg’s dedicated Minister for Health provides a passionate insight into how the country is developing an improved…

Dr. Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA), the Irish regulatory agency, discusses the key objectives of…

Eduardo Gonzalez Pier, former Vice-Minister for Integration and Development of the Health Sector, shares his perspective on current dynamics in…

Novartis Slovakia’s Marianthi Psaha discusses the upcoming shift in Slovakia’s healthcare landscape, the importance of a healthy dialogue between…

José Angel García Hinojosa, counsellor of the board of the Grupo Loeffler Russek, details how Loeffler’s impressive growth has forced the company…

In an exclusive interview, Irish Minister for Foreign Affairs and Trade, Charles Flanagan TD, outlines the Department’s enhanced focus on trade and…

Lukas Engelberger discusses the challenges and benefits of the healthcare system in Switzerland and the Canton of Basel-Stadt, new milestones in…

The benefits of economic growth in the Philippines are slowly starting to trickle down to the poorest in society via a more inclusive and affordable…

As a major innovative hub for (bio)pharma innovation, Ireland should be a place where innovative medicines are adopted quickly within the local…